Learning objectives:

  1. Explain the differences in systemic cancer treatment options.
  2. Describe common toxicities of immunotherapy.
  3. Identify appropriate clinical management of common immune-related adverse events resulting from cancer immunotherapy treatment.
  4. Outline best practices for multidisciplinary management of patients receiving cancer immunotherapy treatment.
Session date: 
05/18/2023 - 12:00pm to 1:00pm CDT
Madison, WI 53792
United States
  • 1.00 AAPA Category 1 CME
  • 1.00 AMA PRA Category 1 Credit
  • 1.00 ANCC Contact Hours
    • 1.00 ANCC Pharmacotherapy Contact Hours
  • 1.00 University of Wisconsin–Madison Continuing Education Hours
    • 1.00 Approved for AMA PRA Category 1 Credit™

Please login or register to take this course.
Discloser List CME Internal Report
Jennifer Pleva, NP